Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.55 USD | -3.24% |
|
-4.27% | +161.46% |
07-02 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
07-02 | Novavax: Health Canada approves Covid 24/25 vaccine | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+161.46% | 1.76B | |
+16.59% | 44.44B | |
-10.62% | 37.68B | |
+40.49% | 39.84B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Transcript : Novavax, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-13-2016 11